Position history for BlackRock, Inc.'s holdings in AVADEL PHARMACEUTICALS PLC
BlackRock, Inc. holds 7M shares of AVDL (AVADEL PHARMACEUTICALS PLC), worth $151.7M as of 2025-Q4. The position was increased (++1.0% shares). AVDL represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$151.7M
Current Shares
7M
Total Value Change
+$94.6M
Total Shares Change
+1.6M
Other major holders of AVDL: ALLIANCEBERNSTEIN L.P., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC
Increased |
| 7M |
+1.0% |
| $151.7M |
| 0.0% |
| $21.54 |
31 |
| 2025-Q3 | Increased | 7M | +2.5% | $106.5M | 0.0% | $15.31 | 31 |
| 2025-Q2 | Increased | 6.8M | +24.8% | $60.2M | 0.0% | $9.20 | 36 |
| 2025-Q1 | Increased | 5.5M | +0.3% | $42.7M | 0.0% | $8.01 | 29 |
| 2024-Q4 | New | 5.4M | - | $57.2M | 0.0% | $10.50 | 41 |